id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0666-0003,FDA,FDA-2009-N-0666,New Animal Drugs in Genetically Engineered Animals,Rule,CFR-Correction,2009-11-12T05:00:00Z,2009,11,2009-11-12T05:00:00Z,,2009-11-12T14:55:34Z,E9-27305,0,0,0900006480a5600f
FDA-2009-N-0666-0002,FDA,FDA-2009-N-0666,Use of Ozone-Depleting Substances; Epinephrine; CFR Correction,Rule,NCR-Notice of Correction,2009-08-11T04:00:00Z,2009,8,,,2009-08-11T17:57:32Z,E9-19297,0,0,0900006480a05856
FDA-2009-N-0666-0001,FDA,FDA-2009-N-0666,New Animal Drugs for Use in Animal Feeds; CFR Correction,Rule,CFR-Correction,2009-03-26T04:00:00Z,2009,3,,,2009-03-26T18:02:55Z,E9-06810,0,0,09000064809306b9